Our Clients
Pharmaceutical
Read More
Biotechnology
Biotechnology companies face a unique set of challenges. Product development is an expensive and time-consuming process with no guarantees of achieving commercialization. Access to capital is a constraint and most companies require external resources such as CROs to conduct their clinical trials.
Medical Devices
Medical device companies, like their biotech counterparts, face the challenge of access to capital in order to fund their clinical development programs. In addition they face stringent regulatory requirements and a need to demonstrate real world evidence of clinical benefit in order to obtain reimbursement from Payors.
Nutraceutical
As the new Health Canada regulations become part of the industry framework, nutraceutical and functional food producers are increasingly having to consider clinical research and/or better published literature to support their claims.
